Abbas Hussain
At a glance: Abbas Hussain is Director at Moderna (MRNA). Their latest SEC Form 4, filed May 4, 2026, reported a sale of $265K. On file: 0 purchase lines ($0) and 2 sale lines ($279K).
Disclosed holdings: about $2.4M of MRNA stock: 12,066 shares reported on their latest Form 4 (filed May 4, 2026), valued at the Nov 19, 2026 close of $200.20. This counts only MRNA shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Director at Moderna, Inc. (MRNA)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Abbas Hussain's InsiderPrint
2 trades from SEC Form 4 filings, 2025 to 2026, drawn as one fingerprint.
- Bump outward: a purchase (0)
- Dent inward: a sale (2)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 4SEC | MRNAModerna, Inc. | Sell Plan | 5,68212,066 held (−32%) | $46.63 | $265K | +329.3% |
| Dec 11SEC | MRNAModerna, Inc. | Sell Plan | 5041,515 held (−25%) | $27.60 | $14K | +625.4% |
- Sell
Director Abbas Hussain sold $265K of MRNA at $46.63 — cuts the stake by 32%; pre-scheduled 10b5-1 plan sale.
- Sell
Director Abbas Hussain sold $14K of MRNA at $27.60 — pre-scheduled 10b5-1 plan sale.
Follow Abbas Hussain
Get one email when Abbas Hussain files a new purchase or sale. Free.
At most one email a day about Abbas Hussain, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.